Bone Grafts and Substitutes Market – A Major Step Towards Regenerative Medicines
A bone graft is used to repair and rebuild diseased bone and transplant bone tissues of the hips, knees, spine, and various other bones in the body. Bone grafts are also used in order to repair the bone loss caused by fractures and cancers. The body accepts the newly implanted graft and provides a framework for growth of new living bone. Bone grafts used in a surgical procedures can be obtained either from the patient’s own body, a donor or can be entirely man-made from natural or synthetic materials. The two most common types of bone grafts used include an allograft, which refers to a bone obtained from a deceased donor or a cadaver that is sterilized and stored in the tissue or bone banks, whereas the other most frequently used bone graft includes autografts, which is obtained from the patient’s own body parts such as ribs, pelvis, wrist, and hips. Apart from autografts and allografts, bone graft substitutes made up of materials with osteoconductive and osteogenerative properties such as ceramics and polymers are also gaining popularity in the market due to the easy availability of these grafts and its nature to promote natural bone growth.
Rise in trauma cases are responsible for accelerating growth of the global bone grafts and substitutes market
Bone grafting is majorly performed in cases of sinus lift, ridge augmentation, fracture repair, nerve repositioning, and dental implantation. Bone damage is majorly attributed to rising incidence of trauma and accident cases across the globe. According to the Centers for Disease Control and Prevention (CDC), around 2.5 million people were hospitalized in the U.S. in 2014, due to accident injuries, indicating high risk of bone damage. This in turn, increases the demand for bone grafts and substitutes. The potential ability of bone grafting to repair the damage using natural mechanism can thus, be helpful and incorporated for bone healing procedures. Moreover, the National Trauma Institute in 2014, revealed that economic burden due to trauma cases increased to US$ 671 billion, including healthcare costs and lost productivity costs. Among geographical regions, North America contributes the maximum share in the bone grafts and substitutes market, owing to the increasing research and development activities in the field of bone grafting, which results in development of innovative bone grafts in the region. For instance, Artoss, Inc., a U.S.- based company introduced a complete line of bone grafts in 2017, which incorporates use of nanotechnology in the production of these grafts. Various other factors such as presence of key operating players and collaborative partnerships among the players are responsible for positioning North America as the largest market for bone grafts and substitutes. On the other hand, Asia Pacific is expected to gain significant traction, owing to the rise in medical tourism as well as development of novel bone graft substitutes by regional players, exhibiting equivalent efficiency at affordable prices.
The global bone grafts and substitutes market was valued at US$ 2,640.1 million in 2016 and is expected to witness a robust CAGR of 5.5% over the forecast period (2017 - 2025).
Figure 1. Global Bone Graft and Substitutes Market, by Region 2017 (US$ Mn)
Consistent development resulting in innovative bone grafting products expected to propel growth of the market
A large number of players are focused on the development of novel products for bone grafting. For instance, in May 2017, the National Chemical Laboratory in India, developed two novel bone graft substitutes that are aimed towards augmenting and regenerating the bones that are lost during accident or injuries. The products are now in clinical trial phase for performance testing and are expected to be available in prices lesser than the currently available imported varieties of the same, leading to emergence of local players in the Asia Pacific market. Moreover, companies are also entering into mergers and acquisitions to strengthen their position in the market. For instance, Kuros Biosciences acquired Xpand Biotechnology in 2016, wherein Kuros will use Xpand’s granular formulation for the production of novel bone graft substitutes. Major players operating the global bone graft and substitutes market include Ace Surgical Supply Co., Inc., NovaBone Product LLC, Medtronic Plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., BioHorizons Implant Systems, Inc., Novadip Biosciences, Orthofix International N.V., Globus Medical, Inc., and Bone Therapeutics SA.
Bone grafts and substitutes are the natural and synthetic products used by the surgeons to repair and reform bones in the spine, hips and knees through a medical procedure known as bone grafting. The bone used during grafting could be natural or synthetic. The most common types of bone grafts used are the autograft and allograft. An autograft comes from patients own body such as hips, pelvis and wrist. Allograft uses bone from deceased donor or a cadaver bone that has been cleaned and stored in the tissue banks. Bone graft substitutes are the synthetic or derived from allografts in varied forms. Synthetic bone grafts are made up of ceramics, composites, and polymer. Bone grafts substitutes are allografts based (Demineralized Bone Matrix), factor based such as transforming growth factor beta (TGF-beta), and platelet derived growth factor (PDGF), fibroblast growth factor (FGF), and bone morphogenetic proteins (BMP) and cell based bone grafts substitutes to generate new tissue alone or placed into support matrix (eg, mesenchymal stem cells). Bone graft and substitutes are primarily used because of fractures, fusion of two bones, bone and tissue regeneration and for bone healing with the implanted devices.
The major factors driving the market are rising incidences of musculoskeletal conditions, increasing base of elderly population and development of biocompatible synthetic bone grafts.
Bone grafts and substitutes market witnessed new product launches, partnerships and agreements in last few months. In October, 2017, DSM Biomedical signed a partnership agreement with a privately held orthobiologics company, Cerapedics to develop peptide enhanced bone graft. The strategic partnership will complement DSM’s material regeneration abilities with Cerapedics synthetic small peptide (P-15) technology. In April, 2017, BoneSupport AB extended its U.S distribution agreement with Zimmer Biomet for its Cerament bone void filler product. According to the agreement Zimmer will have exclusive rights to distribute portfolio of bone void fillers for trauma, orthopedics and foot and ankle applications. In May, 2017, NovaBone introduced NovaBone IRM and IRM MacroPOR to its product portfolio. According to NovaBone, the products possess osteogenic and osteoblastic characteristics and are highly irrigation resistant. Increase in awareness of non-invasive technologies among the patients and shift towards derived forms of bone graft substitutes are also expected to favor the market in near future.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 29 market data tables and 37 figures on "Global Bone Grafts and Substitutes Market” - Global forecast to 2025”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.